InMode Ltd. (FRA:154)

Market Cap	717.08M -15.5%
Revenue (ttm)	327.91M -6.7%
Net Income	67.85M -56.6%
EPS	1.08 -52.0%
Shares Out	n/a
PE Ratio	11.35
Forward PE	10.53
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20
Open	12.32
Previous Close	12.24
Day's Range	12.32 - 12.32
52-Week Range	11.02 - 13.88
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2026

About InMode

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women’s health conditions and procedures. The ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 660
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 154

Financial Performance

In 2025, InMode's revenue was $370.50 million, a decrease of -6.16% compared to the previous year's $394.82 million. Earnings were $93.83 million, a decrease of -48.24%.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error